Biogen Wants MS Drug Approved Globally, CEO Says

April 15 (Bloomberg) -- George Scangos, chief executive officer of Biogen Idec Inc., talks about the drugmaker's first multiple sclerosis pill Tecfidera and the company's drug pipeline. He speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)

Amazon's Presence at the Oscars
48:40 - Hollywood's biggest weekend is just around the corner with the 89th annual Academy Awards on Sunday. We see some familiar names like Meryl Streep and Ryan Gosling, but there is one new player grabbing attention. Bloomberg's Kaitlin Meehan reports on “Bloomberg Technology.” (Source: Bloomberg)
  • The Self-Driving Car Fight Between Google and Uber
  • Lucid Motors Aims to Rival Tesla
  • Personal Capital CEO Says Banks Need to Change Attitude